Wu T J, Teng R J, Tsou Yau K I
Department of Pediatrics, National Taiwan University Hospital, Taipei, ROC.
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1996 Jan-Feb;37(1):56-8.
A female infant, born at the gestational age of 29 weeks with a birthweight of 1,350 gm, developed progressive hepatomegaly at 10 days of age. Congestive heart failure gradually developed, and hepatic hemangioendothelioma was diagnosed at 1 month of age by open biopsy. Due to rapid enlargement of the tumor and progressive heart failure, steroid therapy was given from 36 days of age, including methylprednisolone 15 mg/kg/day for 3 days and 10 mg/kg/day for 4 days, then prednisolone 4 mg/kg/day for 20 days followed by tapering till 74 days of age. The tumor regressed gradually and was not detectable by sonography at 33 months of age. We suggest that, even in very-low-birthweight infants, the prognosis of hepatic hemangioendothelioma may be improved with aggressive therapy when symptoms develop during tumor progression, and that steroid should be the initial treatment.
一名孕29周出生、出生体重1350克的女婴,在10日龄时出现进行性肝肿大。逐渐发展为充血性心力衰竭,1月龄时经开放活检诊断为肝血管内皮瘤。由于肿瘤迅速增大和进行性心力衰竭,从36日龄开始给予类固醇治疗,包括甲基泼尼松龙15毫克/千克/天,共3天,10毫克/千克/天,共4天,然后泼尼松龙4毫克/千克/天,共20天,随后逐渐减量至74日龄。肿瘤逐渐消退,33月龄时超声检查未发现。我们认为,即使是极低出生体重儿,当肿瘤进展期间出现症状时,积极治疗可能改善肝血管内皮瘤的预后,且类固醇应为初始治疗。